Dixie E. Snider, M.D., M.P.H. Senior Advisor, Office of the Director, CDC Update on Approaches to Understanding Human Influenza Transmission November 4,

Slides:



Advertisements
Similar presentations
CDCs 21 Goals. CDC Strategic Imperatives 1. Health impact focus: Align CDCs people, strategies, goals, investments & performance to maximize our impact.
Advertisements

TEN-T Info Day for AP and MAP Calls 2012 EVALUATION PROCESS AND AWARD CRITERIA Anna Livieratou-Toll TEN-T Executive Agency Senior Policy & Programme Coordinator.
Susan Tallett MB BS MEd FRCPC Professor of Paediatrics Member Safety Competencies Steering Committee June 2008 – PS Working Group Paediatric Chairs of.
Agenda Item 3 Charter CPV Board Meeting 26 July 2010.
Proposed Ontario Agency for Health Protection and Promotion Update on Agency Implementation Presentation for: Ontario Society of Nutrition Professionals.
1 Antivirals in the Draft CDC Pandemic Plan David K. Shay Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention.
Challenges of the 2009 H1N1 Pandemic Influenza: Charles Penn Global Influenza Programme World Health Organization Geneva.
Overview of Enforcement for Occupational Exposure to Tuberculosis (TB)
Children’s Social Care Workload Management System (WMS) A Two-fold approach DSLT 16 th November 2010 Updated with new SWRB standards.
Pandemic Influenza: Role and Responsibility of Local Public Health Richard M. Tooker, MD Chief Medical Officer Kalamazoo County Health and Community Services.
George A. Ralls M.D. Dave Freeman Health Services Department September 1st, 2009 INFLUENZA UPDATE.
U. S. Centers for Disease Control and Prevention
1 Novel Influenza A H1N1 Outbreak: The Florida Response Infection Control Considerations: Focus on Personal Protective Equipment.
1 Webinar on: Establishing a Fully Integrated National Food Safety System with Strengthened Inspection, Laboratory and Response Capacity Sponsored by Partnership.
Melissa House, Ph.D.: Public Health Walden University PUBH Instructor: Dr. Robert Marino Spring Qtr, 2011 D ISASTER P REPAREDNESS P ANDEMIC I NFLUENZA.
Preparing Small Business Workplaces for Pandemic Flu.
Pandemic Influenza Preparedness Kentucky Department for Public Health Department for Public Health.
Healthy North Carolina 2020 and EBS/EBI 101 Joanne Rinker MS, RD, CDE, LDN Center for Healthy North Carolina Director of Training and Technical Assistance.
Pandemic Influenza Response Planning on College Campuses Felix Sarubbi, MD Division of Infectious Diseases James H. Quillen College of Medicine.
HealthSanté CanadaCanada Influenza Prevention and Control in Canada Arlene King, MD, MHSc, FRCPC Director, Immunization and Respiratory Infections Division,
Ethics Conference on Asian Flu Pandemic Ethical considerations among Response to H1N1 Pandemic in China China CDC, CFETP Huilai Ma, Guang Zeng.
Fighting the Flu 2010 Managers’ Toolkit. All Rights Reserved, Duke Medicine 2007 Why Get the Flu Vaccine? Because we care about our patients! Looking.
Defence Centre for Occupational Health Presentation to Forum – 4 April 2006.
EULITA / Liese Katschinka Copyright (c) An ISO Standard for Interpreting Services in Judicial Settings Opatija, 20 March
Pan American Health Organization.. Protecting the Health of Health Care Workers: Experience from the Americas Marie-Claude Lavoie Decision Making for Using.
Credentials Committee Orientation. Responsibilities of the Committee Review the credentials of all applicants to the Medical Staff and privileges requests.
UNIVERSITY POLICE OFFICE OF EMERGENCY MANAGEMENT H1N1 Presentation.
Best Practice Guideline for the Workplace During Pandemic Influenza Occupational Health and Safety Employment Standards.
Swine Influenza Information. Update as of 4/28/09 As of 11:00 AM there have been 64 cases reported in the USA. There has not been a confirmed case in.
1 Influenza Vaccination of Health-care Personnel: An Initiative to Improve a Serious Public Health Problem Anand Parekh, MD, MPH Office of Public Health.
Pandemic Influenza Preparedness & Response Part 4: Resources Available to Support Planning Occupational Safety and Health Course for Healthcare Professionals.
FDA Science Board Drug Safety Initiative April 15, 2005 Rockville, MD RADM Steven Galson, MD, MPH Acting Director, Center for Drug Evaluation and Research.
1 EFSA Scientific Panel on Dietetic Products, Nutrition and Allergies (NDA): Work Programme & Future Focus Albert Flynn Chair, NDA EFSA Management Board,
Public Health Issues of Interest Seasonal Influenza Seasonal Norovirus Middle East Respiratory Syndrome Coronavirus Novel Influenza (A/H7N9) David H. Trump,
Revision Process for the PHS Guideline for Reducing HIV, HBV and HCV Transmission through Solid Organ Transplantation Matthew J. Kuehnert, M.D. Office.
Guidance on Antiviral Drug Use and Stockpiling of Antiviral Drugs and Respirators and Facemasks National antiviral drug use guidance Ben Schwartz, HHS.
Smallpox Vaccine Program: Communications with the Public and Stakeholders Department of Health and Human Services Centers for Disease Control and Prevention.
World Health Organization, Regional Office for The Western Pacific Regional Activities Report and Preparation for the Upcoming Influenza Seasons THE 3rd.
Analysis of 2007 BOD Assessment Checklists Prepared by: Cambria Tidwell.
National Commission for Academic Accreditation & Assessment Developmental Reviews at King Saud University and King Faisal University.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Office of Public Health Preparedness and Response Division of Strategic National Stockpile Ben Erickson Public Health Analyst Inventory Management Tracking,
Food and Drug Administration
GOVERNOR’S EARLY CHILDHOOD ADVISORY COUNCIL (ECAC) September 9, 2014.
Governor’s Taskforce for Pandemic Influenza Preparedness Issue Paper Credible and Effective Decision-making Workgroup Members Robert Rolfs, State Epidemiologist,
Standards and Guidance Update Jim Maddux OSHA Directorate of Standards and Guidance.
1 |1 | Situation Update Influenza A (H1N1), 26 May 09.
(Slide 1 of 22) Response to the National Vaccine Advisory Committee Recommendations on the Immunization Safety Office Scientific Agenda Frank DeStefano,
Welcome Expert Panel on Isolation and Quarantine June 2-3,
Reusable Launch Vehicle Working Group Commercial Space Transportation Advisory Committee Presented to COMSTAC Meeting George Whitesides, RLVWG Chairman.
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
NON-ACADEMIC POLICY TIMELINE For February 2010 Policies of great importance or policies that relate to a University regulation may need to go to the BOT.
1 ISWGNA and AEG: Mandate and governance 7 th meeting of the Advisory Expert Group on national accounts Apr 2012, New York.
Influenza A (H1N1) Virus & Pandemic Preparedness – Administrative Issues…
Current Pandemic H1N1 Updates in the Philippines Department of Health, Philippines Juan M. Lopez, MD, PGradDipPH, MPH Aldrin Q. Reyes, RN.
Carolyn B. Bridges, MD Associate Director for Science, Influenza Division, NCIRD, CDC November 4-5, 2010 Charge to Workshop Attendees Approaches to Understanding.
1 | Code of Conduct for School Students Travelling on Buses Australian Bus and Coach Conference 29 September 2014.
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
The Metropolitan Medical Response System Olan Johnston Christine Tolis The New England Center for Emergency Preparedness The Northern New England MMRS.
Done by: Sandra Goodall Liza McGill Elecia Trowers Vivarian Malcolm.
Federal Welcome: A View from the Office of HIV/AIDS and
Technical Consultation: Folate Status in Women and NTD Risk-Reduction
Overview of The Access for All Advisory Committee
Increase compliance of Personal Protective Equipment
U. S. Department of Homeland Security. Office for Civil Rights
World Health Organization
National Consensus Project Clinical Practice Guidelines for Quality Palliative Care, 4th Edition Overview The goal of the National Consensus Project.
Provost Guidelines for Submission of Tenure on Hire Requests to the University Promotion and Tenure Committee.
Strategic Planning Timeline Overview
Ms. Kim Adkins, Chair July 26, 2018
Presentation transcript:

Dixie E. Snider, M.D., M.P.H. Senior Advisor, Office of the Director, CDC Update on Approaches to Understanding Human Influenza Transmission November 4, 2010 Background for this Meeting Office of the Director Office of the Associate Director for Science (OADS)

Outline of Presentation  Selected Chronology of Events since April, 2009  High Level Summary of the “State of the Science”  Why the mode or modes of transmission matter to public health  Conclusion

Chronology of Events  April, 2009 – Outbreaks of disease caused by a novel, influenza A (H1N1) strain are detected in Mexico and the United States.  May, 2009 – CDC issues interim recommendations for infection control in healthcare settings. Based primarily on concerns about the severity of disease caused by this new strain, N95 respirators were recommended rather than surgical masks (the standard for seasonal influenza protection).

Chronology of Events (Continued) June, 2009 – Acting CDC Director orders guidelines for influenza infection control in healthcare settings be reviewed and revised as necessary. External stakeholders are to be engaged. Early July, 2009 – Informal CDC working group is created to carry out the task. Members represent various CDC components with expertise in the area.

Chronology of Events (Continued)  July, 2009 – WG engages external stakeholders, including healthcare infection control experts, occupational health and safety experts, OSHA, and labor unions representing HCP.  July, CDC WG identifies differences of opinion about the use of surgical masks vs. N-95 respirators as a major obstacle to developing consensus guidelines  July, 2009 – IOM is asked by CDC and OSHA to convene a panel to specifically address the respiratory protection issue, without considering “economic and logistical” factors.

Chronology of Events (Continued)  September 1, 2009 – IOM panel meets  September 3, 2009 – IOM panel issues a letter report with two recommendations:  Recommendation 1: Use Fit-Tested N95 Respirators  Recommendation 2: Increase Research on Influenza Transmission and Personal Respiratory Protection “The need for research in a number of areas was striking. Due to the lack of a strong and conclusive evidence base, the committee concluded that determination of the relative contribution of each route of influenza transmission is essential for long-term preparedness planning.”

Chronology of Events (Continued) September 29, 2010 – CDC Director attends meeting at the White House and emerges with a charge to “fast track” research which would close critical knowledge gaps noted by the IOM. October, 2009 – Amidst great controversy, CDC issues new interim infection control guidance which continues to recommend N95 respirators, but attempts to address feasibility and logistical issues. October, 2009 – WHO identifies the mode or modes of influenza transmission as a major knowledge gap.

Chronology of Events (Continued)  October, 2009 – Ten CDC staff members are identified to serve on an “Influenza Research Agenda Steering Committee”. One objective is to create a “fast tack” agenda.  November 2010 – the committee completes its work, presents its proposal to leadership, and receives approval to proceed to implement five projects.

Summary of the “Fast Track” Agenda  Study to understand the modes of influenza transmission  Study of the persistence of viable influenza virus in aerosols  A direct comparison of N95 respirators vs. surgical masks for protection of healthcare personnel  Study of the dispersal of viable airborne influenza viruses and the effect of ultraviolet light  The effect of exclusion policies (e.g., school closures) on influenza transmission

High Level View of “The State of the Science”  The literature on influenza transmission is rather large but is not definitive and often contradictory  There is evidence both for and against each of three modes of transmission, i.e., direct or indirect contact, large droplets, and droplet nuclei (aerosol) transmission  Inappropriate inferences characterize some studies, e.g., close range spread does not necessarily prove large droplet transmission  Study designs often have serious limitations, but optimal designs have not been put forth

Why Does the Mode of Transmission of Influenza Matter to CDC? Guideline Development  Infection control in healthcare settings  Infection control in the workplace  Infection control in schools  Infection control in public transportation settings Purchases for the Strategic National Stockpile Assistance to our Federal, national, state, and local constituencies, e.g., OSHA, SHEA Meet Expectations of the Public Meet Expectations of Executive and Legislative Branches

Conclusions  Events over the past 18 months have brought attention to the fact that the mode or modes of transmission of influenza are not well understood  Filling this knowledge gap would serve a number of public health purposes  We need your individual advice on the optimal way or ways to fill this knowledge gap

Thank you for Coming! Questions ?